BioCatalystWatch
SNTIWorkspace / SNTI / OverviewCompany library
Senti Biosciences, Inc. logo

Senti Biosciences, Inc.

Senti Biosciences, Inc. (SNTI)

Website

Price
Market cap
Next catalystExpected 2026SENTI-202 · Trial initiationCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Other pipelines

SENTI-101

PreINDP1P2P3FilingApproved
SENTI-101

PreINDP1P2P3FilingApproved
SENTI-301

GPC3

PreINDP1P2P3FilingApproved

Partner / License out

SENTI-202

CD33 × FLT3 × EMCN

PreINDP1P2P3FilingApproved
Upcoming / outlook

History / paused

CEA (CEACAM5) × VSIG2

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

SNTI PR & News

PR & News

SNTI SEC archive